Companies: 10,795·Total market cap: $144.5T
ResMed Inc.

ResMed Inc.

RMDNYSEHealthcare● Active
$194.02
$-2.02(-1.03%)
Market Cap$28.1B
P/E Ratio—
52W High$293.81
52W Low$180.27
Overview

ResMed Inc. (RMD) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000943819 · RMD · NYSE · as of Jun 8, 2026

Filing snapshot

1,001+
Total Filings
144
Latest Form
2026-06-08
Most Recent
1995
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0000943819 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-08-08
Fiscal Year End
Aug 8, 2025
Accession No.
0000943819-25-000035
Primary Document
rmd-20250630.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0000943819 · Accession 0000943819-25-000035

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-01
View 10-Q on SEC
8-KCurrent Report
8-K
2026-04-30Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SDSD
SD
2026-05-26
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-05-04
View
10-QQuarterly Report
10-Q
2026-05-01
View
8-KCurrent Report
8-K
2026-04-30
View
8-KCurrent Report
8-K
2026-04-30
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-29
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-29
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-27
View
10-QQuarterly Report
10-Q
2026-01-30
View
8-KCurrent Report
8-K
2026-01-29
View
S-8Employee Stock Plan Registration
S-8
2025-11-21
View
S-8Employee Stock Plan Registration
S-8
2025-11-21
View
8-KCurrent Report
8-K
2025-11-20
View
10-QQuarterly Report
10-Q
2025-10-31
View
8-KCurrent Report
8-K
2025-10-30
View
Showing 1–15 of 175 filingsForm 4 / 144 hidden· 1001 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000943819  |  Exchange: NYSE · Healthcare

ResMed Inc. (NYSE: RMD) has submitted 1,001+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1995. As a Healthcare sector company with CIK 0000943819, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is ResMed Inc.'s most comprehensive regulatory disclosure. The most recent ResMed Inc. 10-K was filed on 2025-08-08 for fiscal year ending 2025. Historical RMD 10-K annual reports are available from 2018 through 2025.

Investors researching ResMed Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
BDX SEC Filings →CAH SEC Filings →HUM SEC Filings →HLN SEC Filings →A SEC Filings →ALC SEC Filings →IQV SEC Filings →GEHC SEC Filings →
→ RMD Financials→ RMD Earnings→ RMD Insider Trades

Frequently Asked Questions

RMD SEC Filings · 8 questions

ResMed Inc. (RMD) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,001+ filings and access original documents at no cost. ResMed Inc.'s CIK is 0000943819.

RMD SEC filingsResMed Inc. SEC documentsfind RMD 10-K